Jennifer Lushis

Jennifer Lushis has over 20 years of experience in Quality Assurance and Regulatory Compliance roles within the pharmaceutical industry. Their most recent position was as the Director of Abecma Quality Product Lead at 2seventy bio, where they provided strategic Quality leadership and oversaw the development of commercial lifecycle management filings. Prior to that, they served as the Director of Quality Operations- External Manufacturing at Taysha Gene Therapies, where they established and led the Quality Operations department and ensured regulatory compliance. Jennifer has also held senior roles at Veloxis Pharmaceuticals, Braeburn Pharmaceuticals, Chiesi USA, Inc., Talecris Plasma Resources, Pharmaceutical Manufacturing & Compliance Associates, Centocor, Synthon, and Covance, where they gained extensive experience in quality system management, regulatory submissions, and compliance auditing.

Jennifer Lushis attended Maryville University of Saint Louis, where they pursued a degree in Management with a focus on Business Administration and Management, General. The specific start and end years of their education are not provided in the available information.